Supported polymetal olefin polymerization catalyst, preparation method and use thereof

    公开(公告)号:US10053523B2

    公开(公告)日:2018-08-21

    申请号:US15535902

    申请日:2015-11-25

    Abstract: The present invention relates to a supported polymetal olefin polymerization catalyst, comprising a porous support, a magnesium-containing support component, a transition metal titanium component supported on the porous support, and further comprising at least one non-magnesium metal component supported on the porous support. Further provided is a preparation method and a use of the supported polymetal olefin polymerization catalyst. An efficient composite support supported polymetal Ziegler-Natta catalyst is provided in the present invention, wherein a porous support, a soluble magnesium compound, and a soluble non-magnesium metal compound are used as raw materials. The supporting of titanium is achieved while a composite support containing magnesium and non-magnesium metal components is formed in situ in the surface of the porous support. The present invention has the advantage of a simple preparation method, a low cost, a controllability of morphology, properties of the catalyst, etc. Comparing the provided catalyst with the same type of magnesium/titanium catalyst free of non-magnesium metal components, the catalytic performance such as polymerization activity, hydrogen regulation sensitivity and copolymerization performance are significantly improved.

    ELECTRIC DESALTING AND DEHYDRATION APPARATUS
    123.
    发明申请

    公开(公告)号:US20180201846A1

    公开(公告)日:2018-07-19

    申请号:US15742044

    申请日:2016-06-21

    Abstract: Provided is an electric desalting and dehydration apparatus, including an oil inlet distributor of an upper electric field, wherein the oil inlet distributor includes an oil inlet distributing pipe and an oil inlet branch pipe. The oil inlet distributing pipe is arranged in a water tray of an electric desalter, and below a ground electrode of the electric desalter. The oil inlet branch pipe is connected to the oil inlet distributing pipe to supply crude oil into the oil inlet distributing pipe. The oil inlet distributing pipe is provided with oil outlets on both sides thereof in a horizontal direction. The distributor can uniformly distribute crude oil in a water tray, thus all of the crude oil is kept in an electric field for an equal time.

    Device for liquid degassing
    127.
    发明授权

    公开(公告)号:US09844742B2

    公开(公告)日:2017-12-19

    申请号:US14764179

    申请日:2014-01-10

    CPC classification number: B01D19/0052 B01D19/0036 B01D19/0057

    Abstract: The present invention relates to a device for liquid degassing by means of swirling or centrifugal force coupled with a pressure gradient. This device comprises a cavity. The cavity is furnished with an inlet for liquid-gas mixture, a gas outlet and a liquid outlet. The gas outlet is inserted into the cavity through the top end of the cavity and positioned around 0.1-3 times the maximum diameter of the cavity from the top of the cavity. Specifically, an overflow pipe with the diameter gradually increasing from the bottom to the top was used as the gas outlet. The overflow pipe is further furnished with a bell mouth at the bottom part.

    Use of fusion protein
    130.
    发明授权
    Use of fusion protein 有权
    使用融合蛋白

    公开(公告)号:US09593151B2

    公开(公告)日:2017-03-14

    申请号:US14653276

    申请日:2013-12-05

    Abstract: Disclosed is the use of a fusion protein in drugs for stimulating differentiation of bone marrow mesenchymal stem cells to hematopoietic stem/progenitor cells, or drugs for proliferation of granulocyte hematopoietic progenitor cells. The fusion protein has a sequence as shown in SEQ ID NO: 2 or SEQ ID NO: 4. The drugs can be used for the prevention and/or treatment of (i) hematopoietic dysfunction caused by chemotherapy, (ii) hematopoietic dysfunction caused by radiotherapy, or (iii) leukopenia.

    Abstract translation: 公开了在药物中使用融合蛋白来刺激骨髓间充质干细胞分化成造血干细胞/祖细胞或用于粒细胞造血祖细胞增殖的药物。 融合蛋白具有如SEQ ID NO:2或SEQ ID NO:4所示的序列。该药物可用于预防和/或治疗(i)由化疗引起的造血功能障碍,(ii)造血功能障碍引起的 放射治疗,或(iii)白细胞减少。

Patent Agency Ranking